リパーパシングドラッグの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR4993)
◆英語タイトル:Global Repurposed Drugs Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR4993
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品、ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥499,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥748,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、リパーパシングドラッグの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(一般医薬品、臨床試験失敗医薬品)、用途別市場規模(心血管疾患、精神疾患、がん、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・リパーパシングドラッグの市場動向
・企業の競争状況、市場シェア
・リパーパシングドラッグの種類別市場規模(一般医薬品、臨床試験失敗医薬品)
・リパーパシングドラッグの用途別市場規模(心血管疾患、精神疾患、がん、その他)
・リパーパシングドラッグの北米市場規模2016-2027(アメリカ、カナダ)
・リパーパシングドラッグの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・リパーパシングドラッグのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・リパーパシングドラッグの中南米市場規模2016-2027(メキシコ、ブラジル)
・リパーパシングドラッグの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Teva、Novartis、Mylan、Johnson & Johnson、Pfizer、Bausch Health、GSK、ChemRar Group、Glenmark、Fujifilm、Dr. Reddy、R-Pharma)
・結論
【レポートの概要】

Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.

Market Analysis and Insights: Global Repurposed Drugs Market
The global Repurposed Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Repurposed Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Repurposed Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Repurposed Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Repurposed Drugs market.

Global Repurposed Drugs Scope and Market Size
Repurposed Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Repurposed Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Generic Drugs
Clinical Trial Failed Drugs

Segment by Application
Cardiovascular Diseases
Mental Illness
Cancer
Other

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Repurposed Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Generic Drugs
1.2.3 Clinical Trial Failed Drugs
1.3 Market by Application
1.3.1 Global Repurposed Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular Diseases
1.3.3 Mental Illness
1.3.4 Cancer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Repurposed Drugs Market Perspective (2016-2027)
2.2 Repurposed Drugs Growth Trends by Regions
2.2.1 Repurposed Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Repurposed Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Repurposed Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Repurposed Drugs Industry Dynamic
2.3.1 Repurposed Drugs Market Trends
2.3.2 Repurposed Drugs Market Drivers
2.3.3 Repurposed Drugs Market Challenges
2.3.4 Repurposed Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Repurposed Drugs Players by Revenue
3.1.1 Global Top Repurposed Drugs Players by Revenue (2016-2021)
3.1.2 Global Repurposed Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Repurposed Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Repurposed Drugs Revenue
3.4 Global Repurposed Drugs Market Concentration Ratio
3.4.1 Global Repurposed Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Repurposed Drugs Revenue in 2020
3.5 Repurposed Drugs Key Players Head office and Area Served
3.6 Key Players Repurposed Drugs Product Solution and Service
3.7 Date of Enter into Repurposed Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Repurposed Drugs Breakdown Data by Type
4.1 Global Repurposed Drugs Historic Market Size by Type (2016-2021)
4.2 Global Repurposed Drugs Forecasted Market Size by Type (2022-2027)

5 Repurposed Drugs Breakdown Data by Application
5.1 Global Repurposed Drugs Historic Market Size by Application (2016-2021)
5.2 Global Repurposed Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Repurposed Drugs Market Size (2016-2027)
6.2 North America Repurposed Drugs Market Size by Type
6.2.1 North America Repurposed Drugs Market Size by Type (2016-2021)
6.2.2 North America Repurposed Drugs Market Size by Type (2022-2027)
6.2.3 North America Repurposed Drugs Market Size by Type (2016-2027)
6.3 North America Repurposed Drugs Market Size by Application
6.3.1 North America Repurposed Drugs Market Size by Application (2016-2021)
6.3.2 North America Repurposed Drugs Market Size by Application (2022-2027)
6.3.3 North America Repurposed Drugs Market Size by Application (2016-2027)
6.4 North America Repurposed Drugs Market Size by Country
6.4.1 North America Repurposed Drugs Market Size by Country (2016-2021)
6.4.2 North America Repurposed Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Repurposed Drugs Market Size (2016-2027)
7.2 Europe Repurposed Drugs Market Size by Type
7.2.1 Europe Repurposed Drugs Market Size by Type (2016-2021)
7.2.2 Europe Repurposed Drugs Market Size by Type (2022-2027)
7.2.3 Europe Repurposed Drugs Market Size by Type (2016-2027)
7.3 Europe Repurposed Drugs Market Size by Application
7.3.1 Europe Repurposed Drugs Market Size by Application (2016-2021)
7.3.2 Europe Repurposed Drugs Market Size by Application (2022-2027)
7.3.3 Europe Repurposed Drugs Market Size by Application (2016-2027)
7.4 Europe Repurposed Drugs Market Size by Country
7.4.1 Europe Repurposed Drugs Market Size by Country (2016-2021)
7.4.2 Europe Repurposed Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Repurposed Drugs Market Size (2016-2027)
8.2 Asia-Pacific Repurposed Drugs Market Size by Type
8.2.1 Asia-Pacific Repurposed Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Repurposed Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Repurposed Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Repurposed Drugs Market Size by Application
8.3.1 Asia-Pacific Repurposed Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Repurposed Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Repurposed Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Repurposed Drugs Market Size by Region
8.4.1 Asia-Pacific Repurposed Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Repurposed Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Repurposed Drugs Market Size (2016-2027)
9.2 Latin America Repurposed Drugs Market Size by Type
9.2.1 Latin America Repurposed Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Repurposed Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Repurposed Drugs Market Size by Type (2016-2027)
9.3 Latin America Repurposed Drugs Market Size by Application
9.3.1 Latin America Repurposed Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Repurposed Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Repurposed Drugs Market Size by Application (2016-2027)
9.4 Latin America Repurposed Drugs Market Size by Country
9.4.1 Latin America Repurposed Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Repurposed Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Repurposed Drugs Market Size (2016-2027)
10.2 Middle East & Africa Repurposed Drugs Market Size by Type
10.2.1 Middle East & Africa Repurposed Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Repurposed Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Repurposed Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Repurposed Drugs Market Size by Application
10.3.1 Middle East & Africa Repurposed Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Repurposed Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Repurposed Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Repurposed Drugs Market Size by Country
10.4.1 Middle East & Africa Repurposed Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Repurposed Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Repurposed Drugs Introduction
11.1.4 Teva Revenue in Repurposed Drugs Business (2016-2021)
11.1.5 Teva Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Repurposed Drugs Introduction
11.2.4 Novartis Revenue in Repurposed Drugs Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Repurposed Drugs Introduction
11.3.4 Mylan Revenue in Repurposed Drugs Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Repurposed Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Repurposed Drugs Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Repurposed Drugs Introduction
11.5.4 Pfizer Revenue in Repurposed Drugs Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Bausch Health
11.6.1 Bausch Health Company Details
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Repurposed Drugs Introduction
11.6.4 Bausch Health Revenue in Repurposed Drugs Business (2016-2021)
11.6.5 Bausch Health Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Repurposed Drugs Introduction
11.7.4 GSK Revenue in Repurposed Drugs Business (2016-2021)
11.7.5 GSK Recent Development
11.8 ChemRar Group
11.8.1 ChemRar Group Company Details
11.8.2 ChemRar Group Business Overview
11.8.3 ChemRar Group Repurposed Drugs Introduction
11.8.4 ChemRar Group Revenue in Repurposed Drugs Business (2016-2021)
11.8.5 ChemRar Group Recent Development
11.9 Glenmark
11.9.1 Glenmark Company Details
11.9.2 Glenmark Business Overview
11.9.3 Glenmark Repurposed Drugs Introduction
11.9.4 Glenmark Revenue in Repurposed Drugs Business (2016-2021)
11.9.5 Glenmark Recent Development
11.10 Fujifilm
11.10.1 Fujifilm Company Details
11.10.2 Fujifilm Business Overview
11.10.3 Fujifilm Repurposed Drugs Introduction
11.10.4 Fujifilm Revenue in Repurposed Drugs Business (2016-2021)
11.10.5 Fujifilm Recent Development
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Details
11.11.2 Dr. Reddy Business Overview
11.11.3 Dr. Reddy Repurposed Drugs Introduction
11.11.4 Dr. Reddy Revenue in Repurposed Drugs Business (2016-2021)
11.11.5 Dr. Reddy Recent Development
11.12 R-Pharma
11.12.1 R-Pharma Company Details
11.12.2 R-Pharma Business Overview
11.12.3 R-Pharma Repurposed Drugs Introduction
11.12.4 R-Pharma Revenue in Repurposed Drugs Business (2016-2021)
11.12.5 R-Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ リパーパシングドラッグの世界市場規模・現状・予測2021年-2027年(Global Repurposed Drugs Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。